ASIC ‘takes aim’ at Over-the-Counter Derivate Distribution and Other High Risk Products
gavel, wood, courtroom-1017953.jpg
Since March 2023, ASIC has taken regulatory action against five issuers of retail OTC derivative products for breaches of DDO. This has resulted in 10 interim stop orders relating to retail OTC derivatives, with further DDO-related investigations of high-risk product issuers underway. ASIC recently commenced its first design and distribution proceedings in the Federal Court against a CFD issuer (23-204MR) and will continue to take appropriate regulatory action where it sees DDO contraventions and risk of consumer harm.
Read More ASIC ‘takes aim’ at Over-the-Counter Derivate Distribution and Other High Risk Products
